Information is posted on this page as a service to our readers. Medications, treatments or procedures discussed in these resources should not be used by healthcare professionals without evaluating the patient, considering risks, contraindications and manufacturers’ product information. Resources may contain promotional content. APNA is not responsible for the content of external websites. Information provided here is not a replacement for a provider’s own due diligence.
For information about these opportunities, please contact:
Elsa Cannon
Manager of Meetings & Sponsorships Email Elsa
APNA Industry Sponsors
Bristol Myers Squibb
Information coming soon.
Johnson & Johnson
Johnson & Johnson Supporting Psychiatric-Mental Health Nurses
Psychiatric-mental health registered nurses and advanced practice registered nurses (PMH RNs and PMH APRNs) are instrumental members of a treatment team with a whole-person approach to patient care. By creating a platform for Psych RNs and APRNs to share their unique experiences, more PMH nurses can connect without being limited by geography. Johnson & Johnson is on a mission to bring hope to people living with psychiatric disorders. With the right care, they can lead a typical life—and that starts with a positive patient-provider relationship. Find content created especially for Psych nurses below, and feel free to share these articles with your colleagues!
LinkedIn articles featuring Hannah Phillips-Hall, PMHNP, Carlos Larrauri, PMHNP, and Levina Kumar, PMHNP-BC, who discuss their individual approaches to care, including how they advocate for their patients, eliminate barriers to medication adherence, and—ultimately—help their patients realize what’s possible with the right treatment plan.
The Mighty article highlighting the expertise of Emma Mangano, DNP, PMHNP-BC, as well as Katie, nurse, mom, and caregiver for her adult son living with schizophrenia.
Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, Parkinson’s disease, endometriosis*, and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid-to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, Twitter, and Facebook. (*in collaboration with AbbVie)
APNA Conferences
We invite you to join is as an exhibitor or sponsor to promote your organization during one of our conferences. We typically have two conferences each year: our APNA Clinical Psychopharmacology Institute (CPI) in June, and the APNA Annual Conference in the Fall. We offer opportunities for product theaters, symposia, exhibits, sponsorships, and advertising. For our Annual Conference we offer the opportunity to submit an abstract for possible presentation. The call for abstracts is posted and sent each Winter and abstracts are selected and confirmed in the Spring. Product theater and symposia offerings are posted in the Fall and typically sell out in mid to late January.
Advertising
We have multiple opportunities for advertising including APNA News, our electronic newsletter, Member Bridge, our members-only community site, and the Journal of the American Psychiatric Nurses Association (JAPNA). Click here for more information.
Industry Partner Program
Our Industry Partner Program is a high-profile, year-round sponsorship with exclusive benefits to connect with the APNA community at-large, and with APNA leadership.
Contact Elsa Cannon, Meetings and Sponsorships Manager, at ECannon@apna.org or 571-533-1741 for more information about any of the above industry opportunities.
Johnson & Johnson Supporting Psychiatric-Mental Health Nurses
Additional Resources:
Depression Looks Like Me is a campaign aimed at normalizing the conversation about depression in the LGBTQ+ community and empowering people to seek the mental health care they may need. Depression Looks Like Me offers a safe space in which the community can see themselves represented in stories, gain access to culturally appropriate resources and providers across intersections of the community, and learn about the different facets of depression so they can make informed decisions with their healthcare teams about their treatment plans. Together, we can show others what depression truly looks like. That depression looks like you, and depression looks like me.
Hope for Schizophreniais an online resource for adults living with schizophrenia and their loved ones. It offers important information about schizophrenia, provides helpful resources, and explains the treatment option landscape, including the benefits of long-acting injectables. Hope for Schizophrenia features the real-life stories from adults living with schizophrenia on the Unseen & Unheard podcast, which aims to combat the stigmas and misconceptions surrounding the condition. By educating and raising awareness, we can work together to bring hope to those living with schizophrenia, their loved ones and caregivers.
Johnson & Johnson Neuroscience US Medical Affairs is now accepting and evaluating Investigator-Initiated Study (IIS) proposals in mood and schizophrenia, including Diversity, Equity, and Inclusion (DE&I)-related research and evidence-based projects. An investigator, early in career or established, may be a healthcare professional who identifies as a practicing clinician, educator, advocate, and/or emerging systems leader who contributes to data generation. Our team has assembled a diverse steering committee of key opinion leaders, including Psych NPs, to elect award winners and provide mentorship throughout the entire process. Ultimately, our goal is to propel healthcare systems to change neuropsychiatry with evidence-based independent research. For more information, please contact your Medical Science Liaison here.
Medical Science Liaison (MSL) Locator – for US HCPs to locate their Johnson & Johnson MSL; see the MSL’s contact information; and easily call, email, text, or schedule a call with the MSL
Chat Live – for Johnson & Johnson brands with a medical information specialist
Call Me Now – for Johnson & Johnson-initiated call to HCP upon request
Call 1-800-526-7736 – for HCP-initiated call to Johnson & Johnson or to report an adverse event or product quality complaint
Email – submit an inquiry for a response from a medical information specialist
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and where solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Johnson & Johnson: Proudly Championing and Supporting Nurses to Advance Health Equity and Transform Health Care
Where would the world be without nurses?
For more than 125 years, Johnson & Johnson has been proud to advocate for and champion the nursing profession through scholarships, leadership and clinical education, career resources, advocacy, and more, as we know that nurses are the backbone of health care. Today, our objective is to attract and strengthen an innovative, thriving, and diverse nursing workforce, empowered to advance health equity and transform health care.
Learn about our resources for nurses and how J&J can support you at nursing.jnj.com.
Neurocrine Biosciences
As a member of APNA, the field medical affairs team at Neurocrine Biosciences is pleased to provide educational resources to assist in your clinical assessment of drug-induced abnormal movements. These abnormal movements may be observed in patients in both inpatient and outpatient psych settings. Recognition and appropriate differentiation of drug-induced movement disorders (DIMDs), including akathisia, drug-induced parkinsonism (DIP), dystonia, and tardive dyskinesia (TD) are imperative to appropriate treatment since improper treatment may make DIMDs worse.
Below are links to several literature-supported resources that may assist in developing your assessment skills. If you have additional questions or seek additional information, please reach out to your respective Clinical Practice Liaison.
Your dynamic community of Psychiatric-Mental Health Nurses.
Connect with fellow psychiatric-mental health nurses, be the first to know about evidence-based resources and programs, and participate in exclusive opportunities to advance the care and treatment of those with mental health & substance use needs.
